Madrigal Pharmaceuticals Stock Price History

MDGL Stock  USD 244.34  2.99  1.24%   
Below is the normalized historical share price chart for Madrigal Pharmaceuticals extending back to February 06, 2007. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Madrigal Pharmaceuticals stands at 244.34, as last reported on the 10th of June, with the highest price reaching 245.11 and the lowest price hitting 227.78 during the day.
IPO Date
6th of February 2007
200 Day MA
205.7961
50 Day MA
227.4468
Beta
(0.41)
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Madrigal Stock, it is important to understand the factors that can impact its price. Madrigal Pharmaceuticals has Sharpe Ratio of -0.0131, which conveys that the firm had a -0.0131% return per unit of risk over the last 3 months. Madrigal Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Madrigal Pharmaceuticals' Risk Adjusted Performance of 0.0059, standard deviation of 3.62, and Mean Deviation of 2.75 to check out the risk estimate we provide.
  
At this time, Madrigal Pharmaceuticals' Common Stock is quite stable compared to the past year. Stock Based Compensation is expected to rise to about 52.2 M this year, although the value of Sale Purchase Of Stock will most likely fall to about 256.7 K. . At this time, Madrigal Pharmaceuticals' Price To Sales Ratio is quite stable compared to the past year. Price Book Value Ratio is expected to rise to 11.20 this year, although the value of Price Earnings To Growth Ratio is projected to rise to (0.76). Madrigal Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0131

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsMDGL

Estimated Market Risk

 3.68
  actual daily
32
68% of assets are more volatile

Expected Return

 -0.05
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.01
  actual daily
0
Most of other assets perform better
Based on monthly moving average Madrigal Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Madrigal Pharmaceuticals by adding Madrigal Pharmaceuticals to a well-diversified portfolio.
Price Book
12.241
Book Value
41.13
Enterprise Value
4.3 B
Enterprise Value Ebitda
(12.33)
Shares Float
12.3 M

Madrigal Pharmaceuticals Stock Price History Chart

There are several ways to analyze Madrigal Stock price data. The simplest method is using a basic Madrigal candlestick price chart, which shows Madrigal Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceMarch 18, 2024283.23
Lowest PriceApril 26, 2024193.33

Madrigal Pharmaceuticals June 10, 2024 Stock Price Synopsis

Various analyses of Madrigal Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Madrigal Stock. It can be used to describe the percentage change in the price of Madrigal Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Madrigal Stock.
Madrigal Pharmaceuticals Price Daily Balance Of Power 0.17 
Madrigal Pharmaceuticals Price Rate Of Daily Change 1.01 
Madrigal Pharmaceuticals Price Action Indicator 9.39 

Madrigal Pharmaceuticals June 10, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Madrigal Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Madrigal Pharmaceuticals intraday prices and daily technical indicators to check the level of noise trading in Madrigal Stock and then apply it to test your longer-term investment strategies against Madrigal.

Madrigal Stock Price History Data

The price series of Madrigal Pharmaceuticals for the period between Tue, Mar 12, 2024 and Mon, Jun 10, 2024 has a statistical range of 89.9 with a coefficient of variation of 8.77. The daily prices for the period are spread out with arithmetic mean of 235.02. The median price for the last 90 days is 236.16. The company underwent 1:35 stock split on 25th of July 2016. Madrigal Pharmaceuticals issued dividends to stockholders on 2016-07-25.
OpenHighLowCloseVolume
06/10/2024
 241.35  245.11  227.78  244.34 
06/07/2024 235.02  245.11  227.78  244.34  467,568 
06/06/2024 236.84  241.50  219.65  241.35  636,455 
06/05/2024 213.00  236.84  208.60  235.97  2,053,697 
06/04/2024 240.00  251.59  238.14  244.35  899,419 
06/03/2024 237.73  245.55  235.78  245.49  329,377 
05/31/2024 226.29  236.72  221.88  236.16  348,423 
05/30/2024 225.89  228.88  223.72  225.49  234,490 
05/29/2024 220.50  224.55  219.39  222.51  263,607 
05/28/2024 233.55  233.55  222.72  223.29  808,191 
05/24/2024 234.81  235.28  228.63  229.58  374,487 
05/23/2024 235.19  239.03  226.78  234.85  446,993 
05/22/2024 241.00  250.34  232.40  235.06  819,907 
05/21/2024 229.67  243.50  226.36  242.49  402,472 
05/20/2024 221.69  232.39  218.90  232.10  313,559 
05/17/2024 217.53  221.52  215.02  220.06  236,438 
05/16/2024 211.89  217.68  210.75  217.17  235,180 
05/15/2024 217.46  219.62  210.05  211.73  392,484 
05/14/2024 214.52  219.76  209.84  210.98  262,278 
05/13/2024 208.78  217.04  205.99  211.32  269,895 
05/10/2024 206.40  208.74  203.86  205.25  234,068 
05/09/2024 208.33  209.99  200.08  206.92  359,471 
05/08/2024 211.52  215.00  201.50  208.04  690,496 
05/07/2024 222.00  230.49  214.96  217.96  780,739 
05/06/2024 231.95  236.65  228.48  235.57  423,461 
05/03/2024 223.35  234.47  221.25  229.84  441,665 
05/02/2024 213.01  218.19  208.77  216.05  451,720 
05/01/2024 203.36  217.82  202.20  210.59  427,526 
04/30/2024 199.40  209.43  199.40  204.02  435,486 
04/29/2024 194.39  202.02  191.18  201.07  357,134 
04/26/2024 192.49  195.58  189.00  193.33  453,346 
04/25/2024 200.63  200.97  190.22  194.38  707,188 
04/24/2024 218.08  220.00  204.16  204.65  575,504 
04/23/2024 212.82  225.66  210.10  218.38  409,540 
04/22/2024 205.19  217.14  197.43  213.49  727,307 
04/19/2024 221.85  224.68  206.03  212.04  625,067 
04/18/2024 227.78  227.90  220.74  222.26  268,860 
04/17/2024 235.91  235.91  224.39  228.34  251,041 
04/16/2024 228.03  235.92  222.90  232.98  343,870 
04/15/2024 237.00  242.99  228.82  231.37  322,925 
04/12/2024 243.09  245.36  236.49  236.59  294,909 
04/11/2024 245.08  248.63  243.25  245.27  216,428 
04/10/2024 242.00  246.23  241.48  244.67  226,258 
04/09/2024 251.41  253.48  244.02  249.34  226,968 
04/08/2024 245.84  248.82  242.20  248.64  238,450 
04/05/2024 240.11  246.34  238.27  243.04  295,978 
04/04/2024 244.39  248.44  240.33  241.46  385,216 
04/03/2024 242.00  247.33  241.13  245.23  490,313 
04/02/2024 248.72  250.94  241.52  244.50  593,301 
04/01/2024 267.28  268.04  254.98  255.74  547,055 
03/28/2024 258.54  268.22  254.75  267.04  441,791 
03/27/2024 250.00  259.55  244.81  258.81  442,702 
03/26/2024 247.00  252.00  246.61  247.62  234,104 
03/25/2024 248.85  257.73  246.54  247.62  394,567 
03/22/2024 258.49  259.95  242.38  248.20  529,973 
03/21/2024 261.64  265.79  251.79  255.27  382,309 
03/20/2024 267.50  267.50  251.01  258.99  674,677 
03/19/2024 275.00  276.67  263.51  265.68  915,039 
03/18/2024 274.48  292.86  272.01  283.23  963,944 
03/15/2024 293.90  299.98  262.00  270.37  2,768,239 
03/14/2024 274.58  276.30  236.62  243.57  1,726,087 

About Madrigal Pharmaceuticals Stock history

Madrigal Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Madrigal is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Madrigal Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Madrigal Pharmaceuticals stock prices may prove useful in developing a viable investing in Madrigal Pharmaceuticals
Last ReportedProjected for Next Year
Common Stock Shares Outstanding18.7 M19.6 M
Net Loss-265.8 M-252.5 M

Madrigal Pharmaceuticals Quarterly Net Working Capital

959.61 Million

Madrigal Pharmaceuticals Stock Technical Analysis

Madrigal Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Madrigal Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Madrigal Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Price Transformation Now

   

Price Transformation

Use Price Transformation models to analyze the depth of different equity instruments across global markets
All  Next Launch Module

Madrigal Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Madrigal Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Madrigal Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Madrigal to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Information and Resources on Investing in Madrigal Stock

When determining whether Madrigal Pharmaceuticals is a strong investment it is important to analyze Madrigal Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Madrigal Pharmaceuticals' future performance. For an informed investment choice regarding Madrigal Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Madrigal Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
For more information on how to buy Madrigal Stock please use our How to buy in Madrigal Stock guide.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Madrigal Pharmaceuticals. If investors know Madrigal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Madrigal Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(23.14)
Return On Assets
(0.40)
Return On Equity
(0.89)
The market value of Madrigal Pharmaceuticals is measured differently than its book value, which is the value of Madrigal that is recorded on the company's balance sheet. Investors also form their own opinion of Madrigal Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Madrigal Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Madrigal Pharmaceuticals' market value can be influenced by many factors that don't directly affect Madrigal Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Madrigal Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Madrigal Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Madrigal Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.